Literature DB >> 18251585

Molecular pathology in anatomic pathology practice: a review of basic principles.

Jennifer L Hunt1.   

Abstract

Molecular testing in pathology emerged shortly after polymerase chain reaction became a standard molecular biology assay. Testing efforts began in the clinical laboratories primarily with assays for genetically inherited diseases and assays for clonality in hematologic malignancies. Today, the field has evolved into "molecular diagnostics," which encompasses testing in almost every area of anatomic pathology. Molecular testing is now even making its way definitively into both surgical pathology and cytopathology, although molecular anatomic pathology is still young with few standard tissue-based molecular assays. As more clinically valuable information is gained from molecular pathology testing of tissues, unique challenges are also becoming apparent at the intersection between tissue diagnosis and DNA diagnosis. This review focuses on basic molecular pathology concepts, with particular emphasis on the challenge of tissue-based testing in anatomic pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18251585     DOI: 10.5858/2008-132-248-MPIAPP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  9 in total

1.  Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

Authors:  Christopher Y Kang; Jonathan Wang; Dierdre Axell-House; Pranay Soni; Mon-Li Chu; Galina Chipitsyna; Konrad Sarosiek; Jocelyn Sendecki; Terry Hyslop; Mazhar Al-Zoubi; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

2.  Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium.

Authors:  Silvia D'Andretta Iglezias; Luiz Alberto Benvenuti; Fiorella Calabrese; Vera Maria Cury Salemi; Ana Maria Gonçalves Silva; Elisa Carturan; Sergio Almeida de Oliveira; Gaetano Thiene; Thales De Brito
Journal:  Virchows Arch       Date:  2008-09-02       Impact factor: 4.064

3.  External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds.

Authors:  Ellen Bellon; Marjolijn J L Ligtenberg; Sabine Tejpar; Karen Cox; Gert de Hertogh; Karin de Stricker; Anders Edsjö; Vassilis Gorgoulis; Gerald Höfler; Andreas Jung; Athanassios Kotsinas; Pierre Laurent-Puig; Fernando López-Ríos; Tine Plato Hansen; Etienne Rouleau; Peter Vandenberghe; Johan J M van Krieken; Elisabeth Dequeker
Journal:  Oncologist       Date:  2011-03-26

Review 4.  Management of EGFR-mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective.

Authors:  M Cabanero; R Sangha; B S Sheffield; M Sukhai; M Pakkal; S Kamel-Reid; A Karsan; D Ionescu; R A Juergens; C Butts; M S Tsao
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677

Review 5.  Cell-blocks and other ancillary studies (including molecular genetic tests and proteomics).

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2021-02-22       Impact factor: 2.091

Review 6.  Pre-analytic steps for molecular testing on thyroid fine-needle aspirations: The goal of good results.

Authors:  Esther Diana Rossi; Fernando Schmitt
Journal:  Cytojournal       Date:  2013-11-28       Impact factor: 2.091

7.  Histological assessment of new cholangioscopy-guided forceps in ERCP biliary stricture sampling: a blinded comparative study.

Authors:  Eric J Vargas; Yaohong Wang; Zongming Eric Chen; Rami Abusaleh; Andrew C Storm; John A Martin; Ryan J Law; Barham K Abu Dayyeh; Michael J Levy; Bret Petersen; Vinay Chandrasekhara
Journal:  Endosc Int Open       Date:  2022-09-14

8.  Diagnostic yield of stereotactic needle-biopsies of sub-cubic centimeter intracranial lesions.

Authors:  J Dawn Waters; David D Gonda; Hasini Reddy; Ekkehard M Kasper; Peter C Warnke; Clark C Chen
Journal:  Surg Neurol Int       Date:  2013-04-17

Review 9.  Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing.

Authors:  Esther Conde; Federico Rojo; Javier Gómez; Ana Belén Enguita; Ihab Abdulkader; Ana González; Dolores Lozano; Nuria Mancheño; Clara Salas; Marta Salido; Eduardo Salido-Ruiz; Enrique de Álava
Journal:  J Clin Pathol       Date:  2021-04-19       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.